Disease induced


Disease-induced compounds are chemical agents used to simulate specific pathological conditions in experimental systems, such as cell cultures, organoids, or animal models.
Disease-induced compounds play a pivotal role in translational biomedical research, allowing researchers to reproduce key features of human diseases under controlled conditions, enabling the study of disease mechanisms and the testing of therapeutic interventions. For example, neurotoxins such as MPTP are widely used to model Parkinson’s disease by selectively damaging dopaminergic neurons, while streptozotocin and alloxan are used to induce diabetes through pancreatic β-cell destruction. Similarly, agents like carbon tetrachloride, bleomycin, and lipopolysaccharide are utilized to reproduce hepatic injury, pulmonary fibrosis, and systemic inflammation, respectively.
Through the application of disease-induced compounds, researchers can bridge the gap between basic molecular research and translational medicine. Their use facilitates the elucidation of disease mechanisms and supports the rational design and preclinical testing of novel therapeutic agents.
-
A8331 Bleomycin Sulfate13 CitationSummary: A chemotherapeutic agent that induces DNA strand breaks, commonly used to construct pulmonary fibrosis animal models. -
B8205 Dextran sulfate sodium salt (MW 35000-45000)7 CitationSummary: A nucleic acid hybridization promoter, commonly used to construct acute and chronic colitis models. -
C6417 Vancomycin3 CitationSummary: An antibiotic that treats bacterial infections by inhibiting bacterial cell wall synthesis; high-dose administration induces acute kidney injury (nephrotoxicity) models in rats/mice. -
A4540 Okadaic acidSummary: A protein phosphatase 1 inhibitor, commonly used to construct Alzheimer's disease (tau hyperphosphorylation) animal models. -
A1042 Angiotensin II35 CitationSummary: A potent vasopressor that selectively activates angiotensin II type 1 receptors (AT1R), commonly used to construct hypertension animal models. -
B5965 Tamoxifen28 CitationTarget: PKCSummary: An orally active selective estrogen receptor modulator (SERM) that can also induce gene knockout in CreER transgenic mice. -
A3966 Doxorubicin40 CitationSummary: DNA topoisomerase II inhibitor -
A1832 Doxorubicin (Adriamycin) HCl15 CitationTarget: TopoisomerasesSummary: A cytotoxic anthracycline antibiotic used in anticancer chemotherapy, commonly used to construct cardiomyopathy (anthracycline cardiotoxicity) animal models. -
N2060 12-O-tetradecanoyl phorbol-13-acetate (PMA)23 CitationSummary: An ERK/MAPK activator, commonly used to construct mouse skin tumor promotion (two-stage carcinogenesis) and acute inflammation animal models. -
B7005 Prostaglandin E23 CitationTarget: Prostaglandin EP receptorsSummary: An endogenous prostaglandin, commonly used to construct PGE2-induced hyperalgesia/allodynia (intrathecal injection) and inflammation-related bone loss animal models.

